US2017189339A1PendingUtilityA1
Abuse deterrent immediate release biphasic matrix solid dosage form
Assignee: SUN PHARMA ADVANCED RES CO LTDPriority: Mar 26, 2014Filed: Mar 23, 2017Published: Jul 6, 2017
Est. expiryMar 26, 2034(~7.7 yrs left)· nominal 20-yr term from priority
A61P 25/24A61P 25/04A61K 9/2009A61K 31/167A61K 9/2013A61K 9/4858A61K 9/2077A61K 9/2054A61K 31/5517A61K 9/4808A61K 31/433A61K 9/4866A61K 9/2027A61K 9/2846A61K 9/2081A61K 9/485A61K 31/137A61K 9/2059A61K 31/135A61K 9/2031A61K 9/5026
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An abuse deterrent immediate release biphasic matrix solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An abuse deterrent immediate release biphasic matrix solid dosage form comprising:
an intragranular phase comprising a mixture of a drug susceptible to abuse and a reverse enteric polymer; an extragranular phase; and an alkalizer, wherein the intragranular phase further comprises a first part of the alkalizer and the extragranular phase comprises a second part of the alkalizer.
2 . The abuse deterrent immediate release biphasic matrix solid dosage form according to claim 1 wherein the drug susceptible to abuse and the reverse enteric polymer are melt extruded to form a solid dispersion characterized by the absence of X-ray diffraction peaks characteristic of the crystalline drug.
3 . The abuse deterrent immediate release biphasic matrix solid dosage form according to claim 1 , further comprising an alcohol dose dumping resistance polymer located only in the intragranular phase.
4 . The abuse deterrent immediate release biphasic matrix solid dosage form according to claim 1 , further comprising an alcohol dose dumping resistance polymer located in both the intragranular phase and extragranular phase.
5 . The abuse deterrent immediate release biphasic matrix solid dosage form according to claim 1 , further comprising an alcohol dose dumping resistance polymer that covers the intragranular phase.
6 . The abuse deterrent immediate release biphasic matrix solid dosage form according to claim 5 , wherein the alcohol dose dumping resistance polymer is also present in the intragranular phase.
7 . The abuse deterrent immediate release biphasic matrix solid dosage form according to claim 6 , wherein the alcohol dose dumping resistance polymer is also present in the extragranular phase.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.